Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure

Background Heart failure (HF) is associated with a hypercoagulable state that predisposes to thromboembolism and anti-coagulation may improve clinical outcomes. The oral, direct Factor Xa inhibitor, rivaroxaban, has not been studied in patients with HF. We hypothesized that rivaroxaban would also re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of heart and lung transplantation 2011-02, Vol.30 (2), p.218-226
Hauptverfasser: Gheorghiade, Mihai, MD, Thyssen, An, PhD, Zolynas, Robert, DVM, MBA, Nadar, Venkatesh K., MD, Greenberg, Barry H., MD, Mehra, Mandeep, MD, Sun, Xiang, PhD, Tian, Hong, PhD, Plotnikov, Alexei N., MD, Burton, Paul, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!